Opana ER

FDA to Remove Pain Drug from the Market

FDA to Remove Pain Drug from the Market

By

The FDA has requested the removal of reformulated Opana ER (oxymorphone HCl; Endo) from the market.

Sign Up for Free e-Newsletters